FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants

Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

Octavio Ramilo, MD, joins us once again to discuss potential benefits of RSV vaccination beyond disease prevention, and to explain how to speak with patients about vaccines and uptake.

FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants

The U.S. Food and Drug Administration (FDA) has approve […] The post FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants first appeared on GeneOnline News. The post FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants appeared first on GeneOnline News.